10 Best Penny Stocks to Buy for 2026

4. Invivyd, Inc. (NASDAQ:IVVD)

Stock Upside Potential: 298.41%

Share price: $2.45

Number of hedge fund holders: 20

Invivyd, Inc. (NASDAQ:IVVD) is one of the best penny stocks to buy in 2026. On January 8, Invivyd, Inc. (NASDAQ:IVVD) reported preliminary fourth-quarter 2025 net product revenue of $17.2 million from PEMGARDA (pemivibart), representing 25% growth year over year and a 31% increase from the prior quarter. The company ended 2025 with $226.7 million in cash and equivalents, strengthened by financing completed in the second half of the year. With a current ratio of 2.47, Invivyd enters 2026 with solid liquidity to support operations and pipeline advancement.

Invivyd has launched its DECLARATION Phase 3 pivotal trial for VYD2311, a monoclonal antibody designed as an alternative to vaccination for COVID-19 prevention. The program received FDA Fast Track designation in December 2025. The triple-blind, randomized study will enroll approximately 1,770 participants, with top-line results expected by mid-2026. Management pointed to continued demand for antibody-based prevention as vaccination rates decline, while PEMGARDA’s 93.3% gross margin highlights the product’s commercial potential.

The company is also broadening its pipeline beyond COVID-19. VBY329, an RSV antibody candidate, is expected to reach IND readiness in late 2026, while a measles antibody program remains in preclinical development with candidate selection planned for early 2026. Management stated existing cash resources are sufficient to fund upcoming clinical and development milestones through 2026.

Invivyd, Inc. (NASDAQ:IVVD) develops next‑generation antibody drugs aimed at long‑lasting effectiveness against evolving viruses, leveraging a proprietary platform to deliver durable therapies.